Skip to main content

Table 1 Patient demographics and disease characteristics, NM: not mentioned

From: Takotsubo syndrome associated with cardioversion: a systematic review

Study

Age

Sex

Co morbidities

Cardioverted rhythm

Joules applied HO

Time to develop TS (hours)

Complications

Cardiovascular, inotropic or mechanical support needed

Alishetti2018 [12]

77

F

NM

Atrial flutter

150

 < 1

Cardiogenic shock, heart failure

Dopamine switched to epinephrine drip

Buchter [13]

66

F

Hypertension

Atrial fibrillation

NM

NM

Thromboembolism, Cardiogenic shock

NM

Eggleton 14]

76

F

Smoker, Hyperlipidemia, Hypertension

Atrial fibrillation

NM

10

Pulmonary edema, cardiogenic shock

Dopamine

McCutcheon [15]

87

F

Hypertension, Hyperlipidemia, Mitral Valve Prolapse, Chronic Kidney Disease,

Atrial fibrillation

100

28

Pulmonary edema, Heart failure

None

Pir [16]

81

F

Hypertension

Atrial fibrillation

150

48

Pulmonary edema, Heart failure

None

Shah [17]

87

F

Hypertension, Hyperlipidemia

Atrial fibrillation

200

24

Heart failure, Died on post-hospital follow-up

None

Siegfried [18]

67

F

Hypertension

Atrial fibrillation

200

NM

Cardiogenic shock

Epinephrine, vasopressin and dobutamine

Smyrlis [19]

61

F

Hypertension

Atrial fibrillation

120

4

Pulmonary edema, Heart failure

None

Vizzardi [20]

81

F

Hypertension, Hyperlipidemia

Atrial fibrillation

NM

24

Pulmonary edema, Cardiogenic shock

Dobutamine, dopamine

Zaghlol [21]

73

M

Hypertension, Hyperlipidemia

Atrial flutter

200

3

Heart failure, pulmonary edema

None

Valentino [22]

84

F

Hypertension

Atrial flutter

NM

immediately

NM

NM